JACKSONVILLE, Fla., June 5, 2025 /PRNewswire/ — Advanced Biological Research Group (ABRG), a 501c3, has announced its second study to determine the effects of mRNA on women’s reproductive systems. The group’s 2024 pilot study focused on abnormal vaginal bleeding after exposure to mRNA and also the impact of mRNA shedding.
The new 2025 study will investigate the causes of the decrease in ovarian egg reserve and the overall decline in female fertility, as reported by a growing number of OB/GYNs globally.
The ABRG team includes founding members Kimberly Biss, MD, Kirstin Cosgrove BM, CCRA, Ryan Cole, MD, Dan McDyer, MD, noted specialist in maternal-fetal medicine, James A. Thorp, MD. and Dr. Steven J. Hatfill Emeritus, who now serves as Senior Adviser to the Secretary of Health and Human Services (HHS).
Dr. Thorp recently testified in front of the Senate Permanent Sub-Committee on Investigations (Senator Ron Johnson, WI [Chairman]; Senator Richard Blumenthal, CT [Ranking Member]) on the issue of mRNA vaccine adverse effects in the most vulnerable patients: pregnant woman, the unborn and newborn children. Members Dr. Biss and Dr. Cole had testified previously on several topics, including adverse effects in reproduction and the mRNA platform.
For information on supporting ABRG and its studies, please contact:
396338@email4pr.com or visit abrg.org.
Please direct all media inquiries to RECURSION MEDIA GROUP Inc. 396338@email4pr.com or 352-282-0778, or visit recursionmediagroup.com.
Recursion Media Group, Inc. (RMG) owns and operates Recursion Publishing, RMG Innovations, Recursion.Live, and RMG News Daily. For more information, please visit recursionmediagroup.com
SOURCE Advanced Biological Research Group
GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…
This app will connect people with strangers to meditate together in the real world—an invitation…
Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and…
ATLANTA, Dec. 19, 2025 /PRNewswire/ -- Switchboard, MD is proud to announce a new enterprise partnership with…
MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions,…
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Medome is the first AI technology for Personal Health…